AKT1 and glioblastoma: This suggest that in contrast to acute drug inhibition using small molecules and inhibitors that decrease proliferation of GBM cells, the long-term knockdown may allow for compensatory PI3K/AKT signaling that promotes tumor growth, make it vulnerable to PI3K inhibition (209).